￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Crizotinib has significant anti-cancer effect on ROS1-rearranged advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Nivolumab returns to the "battlefield" and joins forces with chemotherapy to help treat non-small cell lung cancer

2025-10-19 11:44:20

Check Details
FDA Grants Crizotinib Breakthrough Drug for ROS1-Rearranged Advanced Non-Small Cell Lung Cancer_Cornhule

2025-10-19 11:44:20

Check Details
A new first-line treatment option for ALK-positive non-small cell lung cancer-crizotinib

2025-10-19 11:44:20

Check Details
The emergence of larotrectinib gives lung cancer patients an additional choice

2025-10-19 11:44:20

Check Details
Can larotrectinib treat small cell lung cancer?

2025-10-19 11:44:20

Check Details
The effect of crizotinib in the treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How effective is the neoadjuvant drug nivolumab monotherapy in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Is the anti-cancer drug larotrectinib included in medical insurance? How much does a box cost?

2025-10-19 11:44:20

Check Details
Can lung squamous cell carcinoma without mutations be treated with afatinib?

2025-10-19 11:44:20

Check Details
Is afatinib a second-line treatment for lung squamous cell carcinoma?

2025-10-19 11:44:20

Check Details
The efficacy of nivolumab combined with ipilimumab in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识